1-(7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)-N-(4-fluorobenzyl)methanesulfonamide

Catalog No. :
ACOIYH604
CAS No. :
1022239-70-8
Molecular Formula :
C17H22FNO3S
Molecular Weight :
339.43

IUPAC Name:1-(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)-N-(4-fluorobenzyl)methanesulfonamide

1-(7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)-N-(4-fluorobenzyl)methanesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$121.00Login to see priceInquiryInquiry
10mg98%$147.00Login to see priceInquiryInquiry
50mg98%$208.00Login to see priceInquiryInquiry
100mg98%$274.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)-N-(4-fluorobenzyl)methanesulfonamide
IUPAC Name1-(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)-N-(4-fluorobenzyl)methanesulfonamide
Molecular FormulaC17H22FNO3S
Molecular Weight339.43
SMILESO=S(CC1(C2(C)C)C(CC2CC1)=O)(NCC3=CC=C(F)C=C3)=O
InChI KeyOLJYOUUYADDDJN-UHFFFAOYSA-N
Synonym1-(((((4-FLUOROPHENYL)METHYL)AMINO)SULFONYL)METHYL)-7,7-DIMETHYLBICYCLO[2.2.1]HEPTAN-2-ONE;1-{7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl}-N-[(4-fluorophenyl)methyl]methanesulfonamide;Bicyclo[2.2.1]heptane-1-methanesulfonamide, N-[(4-fluorophenyl)methyl]-7,7-dimethyl-2-oxo-
CAS No.1022239-70-8

Synthetic Route by SureRoute

1. ACOIYH604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHQGZ976 route compound structure diagram
    ACHQGZ976659-41-6 In Stock
  4. Then
  5. ACOIYH604 route product structure diagram
    ACOIYH6041022239-70-8
Inquiry

2. ACOIYH604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOIYH604 route product structure diagram
    ACOIYH6041022239-70-8
Inquiry

Comments (0)